DDrare: Database of Drug Development for Rare Diseases

Rituximab (arm b) (DrugBank: Rituximab)

2 diseases

ID	Disease name (Link within this page)	Number of trials
43	Microscopic polyangiitis	1
44	Wegener granulomatosis	1

43. Microscopic polyangiitis [ 85 clinical trials, 80 drugs, (DrugBank: 19 drugs), 13 drug target genes, 85 drug target pathways]

Searched query = "Microscopic polyangiitis", "MPA"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 85 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01731561 (ClinicalTrials.gov)	November 16, 2012	12/10/2012	Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis	MAINtenance of Remission Using RITuximab in Systemic ANCA-associated Vasculitis II	Granulomatosis With Polyangiitis;Microscopic Polyangiitis;Renal Limited Forms	Drug: Rituximab (Arm B);Drug: Rituximab (Arm A)	Assistance Publique - Hôpitaux de Paris	NULL	Completed	18 Years	N/A	All	166	Phase 3	France

44. Wegener granulomatosis [ 84 clinical trials, 88 drugs, (DrugBank: 22 drugs), 13 drug target genes, 37 drug target pathways]

Searched query = "Wegener granulomatosis", "Multiple vasculitis granulomatous disease", "Granulomatosis with polyangiitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 84 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01731561 (ClinicalTrials.gov)	November 16, 2012	12/10/2012	Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis	MAINtenance of Remission Using RITuximab in Systemic ANCA-associated Vasculitis II	Granulomatosis With Polyangiitis;Microscopic Polyangiitis;Renal Limited Forms	Drug: Rituximab (Arm B);Drug: Rituximab (Arm A)	Assistance Publique - Hôpitaux de Paris	NULL	Completed	18 Years	N/A	All	166	Phase 3	France